DiaSorin S.p.A.

DIA

IT0003492391

Medical Equipment, Supplies & Distribution

Market Closed - Borsa Italiana Other stock markets 11:45:00 2026-05-14 am EDT			After hours 01:11:05 pm
69.46 ^EUR	-1.53%		69.24	-0.32%

12:49pm	European markets rise following China-US summit; Stellantis gains	AN
12:02pm	European markets climb following China-US summit; Stellantis gains	AN

Carlo Rosa's Sarago 1 acquires over 9,200 DiaSorin ordinary shares

Published on 03/24/2026 at 11:09 am EDT

Alliance News - Translated by Marketscreener - See original

DIASORIN S.P.A.

-1.53%

(Alliance News) - DiaSorin Spa announced on Tuesday that Sarago 1 Srl, a company linked to Carlo Rosa, has purchased 9,211 ordinary shares in the company.

The shares were acquired at an average unit price of EUR54.20, for a total consideration of EUR499,236.20.

DiaSorin shares are currently trading up 3.4% at EUR57.52 per share.

By Giuseppe Fabio Ciccomascolo, Alliance News senior reporter

Comments and questions to redazione@alliancenews.com

Latest news about DiaSorin S.p.A.

12:49pm	European markets rise following China-US summit; Stellantis gains	AN
12:02pm	European markets climb following China-US summit; Stellantis gains	AN
May. 13	Futures rise as focus shifts to Trump in China	AN
May. 12	Sell-off hits European equities; STM drags down MIB	AN
May. 12	Futures bearish; quarterly growth for MPS	AN
May. 11	Europe in the green except Paris, MIB climbs with DiaSorin	AN
May. 11	DiaSorin: Tough quarter, but margins beat and guidance stood firm
May. 11	Buy-side prevails on MIB; DiaSorin shows strength	AN
May. 11	Bullish bias on MIB; crude prices propel Saipem	AN
May. 11	U.S. Futures Fall, European Stocks Mixed	DJ
May. 11	Italy - Factors to watch on May 11	RE
May. 08	DiaSorin S.p.A., Q1 2026 Earnings Call, May 08, 2026
May. 08	DiaSorin acquires over 330,000 treasury shares	AN
May. 08	Italy's DiaSorin posts 28% Q1 profit decline on weak flu season	RE
May. 08	DiaSorin reports lower Q1 metrics; 2026 guidance confirmed	AN

Mr. Carlo Rosa is a Chief Executive Officer, Executive Director & GM at DiaSorin SpA and a Director & Partner at Sarago SRL. He is on the Board of Directors at DiaSorin SpA, Diasorin, Inc., Istituto Italiano di Tecnologia, Transgenic Operative Products SRL and Sarago SRL. Mr. Rosa was previously employed as a Deputy Chairman by Assobiotec, a Managing Director by DiaSorin Deutschland GmbH, and a Director-Infectious Disease Business Unit by Incstar Corp. He received his undergraduate degree from the University of Turin.

View full profile

Chart DiaSorin S.p.A.

Duration

Period

DIA: Dynamic Chart

Company Profile

DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2024, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.

Employees

3,242

Sector

Medical Equipment, Supplies & Distribution

Calendar

May. 18 - Ex-dividend date - 1.3 EUR

More about the company